Aviad Pato

Aviad Pato

Company: Gamida Cell

Job title: Head of NK Research


Utilising Next Generation Gene Editing Techniques to Engineer Novel NK Cells & Overcome Regulatory Hurdles 9:00 am

Utilising mRNA gene editing and CRISPR/Cas9 to generate knock-outs and cytokine knock-ins for increased therapeutic action Highlighting in vitro and in vivo data showing improved therapeutic action of CAR-NK therapies Assessing the potential for genome toxicity of CRISPR and mRNA gene editing to maximise product safetyRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.